Hikal News

Castilia Life Sciences converts to LLP, acquires Hikal stake

Castilia Life Sciences Private Limited has converted to LLP structure, with 3,02,31,914 Hikal shares (24.52%) now vesting in the new entity following MCA approval on 17th February 2026.

Hikal Limited Q3 & 9M FY26 Earnings Call on Feb 11

Hikal Limited announces earnings conference call scheduled for February 11, 2026 at 4:30 PM IST to discuss Q3 and nine months FY26 financial and operational performance with senior management participation.

Hikal discloses revenue recognition irregularities

Hikal Limited reports misconduct by employees involving revenue recognition irregularities affecting Q4FY25, Q1FY26, and Q2FY26, with ₹80.70 cr revenue reversal in Q2FY26. Company confirms all underlying sales are genuine.

Hikal Ltd Shares Transfer to Castilia Life Sciences via Amalgamation Scheme

Shares of Hikal Limited previously held by Shri Rameshwara Investment Private Limited and Shri Badrinath Investment Private Limited have been transferred to Castilia Life Sciences Private Limited through an amalgamation scheme. The scheme was sanctioned under Section 233 of the Companies Act, 2013 on 18 November 2025 and became effective on 1 December 2025, affecting the shareholding structure of Hikal Limited.